CO4770973A1 - Quinolinas - Google Patents

Quinolinas

Info

Publication number
CO4770973A1
CO4770973A1 CO96059775A CO96059775A CO4770973A1 CO 4770973 A1 CO4770973 A1 CO 4770973A1 CO 96059775 A CO96059775 A CO 96059775A CO 96059775 A CO96059775 A CO 96059775A CO 4770973 A1 CO4770973 A1 CO 4770973A1
Authority
CO
Colombia
Prior art keywords
benzo
quinoline
pharmaceutically acceptable
addition salt
oxide
Prior art date
Application number
CO96059775A
Other languages
English (en)
Spanish (es)
Inventor
Rainer Luond
Villar Esteban Pombo
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CO4770973A1 publication Critical patent/CO4770973A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CO96059775A 1995-11-14 1996-11-13 Quinolinas CO4770973A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9523267.4A GB9523267D0 (en) 1995-11-14 1995-11-14 Organic compounds

Publications (1)

Publication Number Publication Date
CO4770973A1 true CO4770973A1 (es) 1999-04-30

Family

ID=10783856

Family Applications (1)

Application Number Title Priority Date Filing Date
CO96059775A CO4770973A1 (es) 1995-11-14 1996-11-13 Quinolinas

Country Status (17)

Country Link
EP (1) EP0873338A1 (cs)
JP (1) JPH11515000A (cs)
KR (1) KR19990067574A (cs)
CN (1) CN1202170A (cs)
AU (1) AU7570996A (cs)
BR (1) BR9611504A (cs)
CA (1) CA2235126A1 (cs)
CO (1) CO4770973A1 (cs)
CZ (1) CZ149498A3 (cs)
GB (1) GB9523267D0 (cs)
HU (1) HUP9903492A3 (cs)
MX (1) MX9803839A (cs)
PE (1) PE17598A1 (cs)
PL (1) PL326636A1 (cs)
SK (1) SK63998A3 (cs)
TR (1) TR199800851T2 (cs)
WO (1) WO1997018208A1 (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2715683A1 (en) 1999-08-21 2001-03-01 Nycomed Gmbh Synergistic combination
WO2002094321A1 (fr) 2001-05-23 2002-11-28 Tanabe Seiyaku Co., Ltd. Compositions favorisant la guérison d'une fracture osseuse
ES2427930T3 (es) 2001-05-23 2013-11-04 Mitsubishi Tanabe Pharma Corporation Composición terapéutica para el tratamiento regenerativo de enfermedades de los cartílagos
GEP20084439B (en) * 2004-01-23 2008-07-25 Amgen Inc Nitrogen-containing heterocyclic derivatives and pharmaceutical use thereof
JP2006347936A (ja) 2005-06-15 2006-12-28 Bayer Cropscience Ag 殺虫性ベンズアニリド類
EP2569285A1 (en) 2010-05-10 2013-03-20 Gilead Sciences, Inc. Bifunctional quinoline derivatives
US8367829B2 (en) 2010-05-10 2013-02-05 Gilead Sciences, Inc. Bi-functional pyrazolopyridine compounds
MX358508B (es) 2012-10-16 2018-08-22 Janssen Pharmaceutica Nv Moduladores de quinolinilo unidos a metileno de receptor nuclear de acido retinoico-gamma-t.
ES2628365T3 (es) 2012-10-16 2017-08-02 Janssen Pharmaceutica N.V. Moduladores de quinolinilo unidos a fenilo de ROR-GAMA-T
US9303015B2 (en) 2012-10-16 2016-04-05 Janssen Pharmaceutica Nv Heteroaryl linked quinolinyl modulators of RORγt
EP3057421B1 (en) 2013-10-15 2019-11-20 Janssen Pharmaceutica NV Alkyl linked quinolinyl modulators of ror(gamma)t
US9284308B2 (en) 2013-10-15 2016-03-15 Janssen Pharmaceutica Nv Methylene linked quinolinyl modulators of RORγt
US9328095B2 (en) 2013-10-15 2016-05-03 Janssen Pharmaceutica Nv Heteroaryl linked quinolinyl modulators of RORgammat
CA2927182A1 (en) 2013-10-15 2015-04-23 Janssen Pharmaceutica Nv Quinolinyl modulators of ror.gamma.t
US9403816B2 (en) 2013-10-15 2016-08-02 Janssen Pharmaceutica Nv Phenyl linked quinolinyl modulators of RORγt
US9221804B2 (en) 2013-10-15 2015-12-29 Janssen Pharmaceutica Nv Secondary alcohol quinolinyl modulators of RORγt
US10555941B2 (en) 2013-10-15 2020-02-11 Janssen Pharmaceutica Nv Alkyl linked quinolinyl modulators of RORγt
EP3813532B1 (en) * 2018-06-24 2024-02-28 Adama Agan Ltd. Process for the preparation of quinmerac

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9027055D0 (en) * 1990-12-13 1991-02-06 Sandoz Ltd Organic compounds
US5455252A (en) * 1993-03-31 1995-10-03 Syntex (U.S.A.) Inc. Optionally substituted 6,8-quinolines

Also Published As

Publication number Publication date
CN1202170A (zh) 1998-12-16
MX9803839A (es) 1998-09-30
HUP9903492A2 (en) 2000-07-28
BR9611504A (pt) 1999-03-02
TR199800851T2 (xx) 1998-08-21
EP0873338A1 (en) 1998-10-28
KR19990067574A (ko) 1999-08-25
SK63998A3 (en) 1998-10-07
WO1997018208A1 (en) 1997-05-22
JPH11515000A (ja) 1999-12-21
CZ149498A3 (cs) 1998-08-12
HUP9903492A3 (en) 2000-08-28
AU7570996A (en) 1997-06-05
CA2235126A1 (en) 1997-05-22
PE17598A1 (es) 1998-04-06
GB9523267D0 (en) 1996-01-17
PL326636A1 (en) 1998-10-12

Similar Documents

Publication Publication Date Title
CO4770973A1 (es) Quinolinas
CY2119B1 (en) Tetrazole derivatives of bile acids a process for their production and their use as medicines
MY113274A (en) Omeprazole magnesium salt form
HUT59558A (en) New 5-chloro-quinoline-8-oxy-alkane-carboxylic acid derivatives, process for producing and utilizing them as antidotum
PH25156A (en) Pyrimidine derivatives, process for their production and herbicidal method and compositions
ZA98496B (en) Process for the production of acetic acid.
PL326322A1 (en) Ciral methylphenyloxyazolydinones
HUP9901285A3 (en) Process for the production of difluoromethane
IL115301A0 (en) Process for the manufacture of starch products
ATE212031T1 (de) Metallocen-phosphoramidit-konjugate, verfahren zu ihrer herstellung sowie deren verwendung
GR930100090A (el) Μέ?οδος για την παραγωγή αλάτων κλαβουλανικού οξέος.
BR9508280A (pt) Processo de fabricação de item de aço de alta-intensidade
YU12000A (sh) Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova
NZ325259A (en) Phospholipid derivatives of phosphono-carboxylic acids, the production of said derivatives and the use of said derivatives as antiviral medicaments
ITMI922692A1 (it) Medicamenti e preparazioni pure di dicloridrato di melarsomina, processo per il loro ottenimento e prodotti intermedi ottenuti
KR0156581B1 (en) 1,4-benzothiazine-2-acetic acid derivatives and process for production
HUT71793A (en) 2,4-diamino-3-hydroxy-carboxylic acid derivatives, pharmaceutical compns. contg. them and process for producing the said compds.
PL311002A1 (en) Method of obtaining aminomethanophosphonic acid
BG105326A (en) Novel benzoylguanadine derivatives with advantageous properties, method for producing them and their use in the production of medicaments
CA2353680A1 (en) Process for the production of cyclene
CA2370145A1 (en) Process of preparing a high-energy softening agent
CA2238304A1 (en) Nitric acid production and recycle
AU1552701A (en) Process for the production of 5-oxy-7-oxabicyclo-(4.1.0)hept-3-E NE-3-carboxylic acid esters
IT8722683A0 (it) Procedimento perfezionato per laproduzione di flessibile di gasolio di elevata qualita'.
AU1514092A (en) Improved process for the production of phosphated guar